An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD

NCT05779566 ·Status: COMPLETED

Anastrozole and Letrozole

NCT00762294 ·Status: COMPLETED

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)

NCT01908556 ·Status: UNKNOWN ·Phase: PHASE4

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

NCT00300508 ·Status: COMPLETED ·Phase: PHASE3

Breast Cancer Tumor Care Observational Programme

NCT00660244 ·Status: COMPLETED

Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

NCT03665077 ·Status: COMPLETED ·Phase: NA

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer

NCT00082277 ·Status: COMPLETED ·Phase: PHASE4

Arimidex Bone Mass Index and Oral Bisphosphonates

NCT00809484 ·Status: COMPLETED

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00309491 ·Status: COMPLETED ·Phase: PHASE3

ATAC - Bone Density Sub-Protocol

NCT00784940 ·Status: COMPLETED ·Phase: PHASE3

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

NCT00963417 ·Status: COMPLETED ·Phase: NA

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

NCT00516698 ·Status: COMPLETED

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

NCT00038103 ·Status: COMPLETED ·Phase: PHASE2

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

Effect of Aromatase Inhibitors on Bones and Genes

NCT00603967 ·Status: COMPLETED ·Phase: NA

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986 ·Status: COMPLETED ·Phase: PHASE4

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

NCT00301457 ·Status: COMPLETED ·Phase: PHASE3

Breast Cancer Women on Aromatase Inhibitors Treatment

NCT03811509 ·Status: UNKNOWN ·Phase: PHASE4

Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy

NCT01613560 ·Status: UNKNOWN ·Phase: PHASE2

Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer

NCT02161315 ·Status: UNKNOWN

Secondary Adjuvant Long Term Study With Arimidex

NCT00295620 ·Status: COMPLETED ·Phase: PHASE3

Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

NCT00542594 ·Status: TERMINATED

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00291759 ·Status: COMPLETED ·Phase: PHASE3

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3